Dr. Edward M. Uchio, MD

Dr. Uchio practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Uchio's NPI, 1588648570, was assigned on December 2, 2005. Dr. Uchio graduated from UC Irvine School of Medicine in 1995. Dr. Uchio holds California license C54951.

Dr. Uchio's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Uchio's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Uchio is also affiliated with MemorialCare Saddleback Medical Center. The medical group on file is UCI Health Center for Urological Care.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Uchio practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Uchio's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Uchio is board certified in urology by the American Board of Urology. Dmand AI has Dr. Uchio's licenses on file in 4 states: California, Washington, Connecticut and Maryland.

Dmand AI lists enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney removal surgery, kidney stone disease, prostate cancer, testicular dysfunction, transurethral procedures and urinary endoscopy among the conditions Dr. Uchio treats.

CMS data shows 1,166 Medicare services from Dr. Uchio across 14 procedure codes in 2024, for 335 Medicare patients. Medicare paid $85,894 for them.

CMS counts 335 Medicare patients who saw Dr. Uchio in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have high cholesterol, and 74% have cancer. 16% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Uchio's median patient age at 71, with 11% women.

In 2024, Dr. Uchio wrote 512 Medicare Part D claims for 146 patients. 55% of them were for generic drugs. CMS names the drug for 464 of them, across 11 drugs with 11 or more claims each, at $1,665,572 in total drug cost. In 2023, CMS named 449 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Uchio for performance year 2024, reported through an alternative payment model (APM). Dr. Uchio accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Uchio as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 131 papers to Dr. Uchio, published from 2004 to 2025. 2017 was the busiest year, with 7. The most frequent topics are Prostatic Neoplasms, Urinary Bladder Neoplasms and Japan. Dr. Uchio has published most often in J Urol. Dr. Uchio's most frequent co-authors are Greg Everett Gin, MD, John Concato, MD and Roozbeh Houshyar, MD.

Dmand AI links Dr. Uchio to 11 clinical trials, 2 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms, Non-Muscle Invasive Bladder Neoplasms and Prostatic Hyperplasia. Merit Medical Systems, Inc. sponsors the most, 2.

CMS Open Payments shows 1,129 general payments to Dr. Uchio from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Pfizer Inc. paid the most, $456,355. It also lists 8 research payments totaling $7,790 from 2023 to 2025.

Dmand AI lists 26 awards for Dr. Uchio, most recently Top Urologist CA in 2013.

Dr. Uchio graduated from UC Irvine School of Medicine in 1995. Dr. Uchio is a member of ACS and SLS.

Dr. Uchio is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.